Tower Research Capital LLC (Trc) Pacira Bio Sciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.29 Billion
- Q1 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,411 shares of PCRX stock, worth $36,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,411
Previous 3,654
61.38%
Holding current value
$36,333
Previous $68,000
48.53%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding PCRX
# of Institutions
254Shares Held
51.1MCall Options Held
157KPut Options Held
139K-
Black Rock Inc. New York, NY8.01MShares$206 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.24MShares$135 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.26MShares$58.3 Million0.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.24MShares$57.7 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.05MShares$52.8 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.18B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...